In the Lira Pump study, they decreased basal insulin by 10%, but increased bolus by 15% ( Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes
This affects multiple organs, and results in consequences including demineralization of bone, hyperglycemia, and obesity, suggesting that GPRC6a plays a role in the coordination of nutrient sensing and metabolism in these tissues (141)
Eight-hundred and eighty-two (41%) received GLP-1RAs, and 1261 (59%) received control (placebo or insulin or no GLP-1RA)
Support health by focusing on a diet rich in glutathione precursors and considering direct supplementation with whey protein-encapsulated glutathione.* [1] National Center for Biotechnology Information